Baird Financial Group, Inc. Repligen Corp Transaction History

Baird Financial Group, Inc.

$47.3 Billion
Q1 2024

A detailed history of Baird Financial Group, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 465,503 shares of RGEN stock, worth $69.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

465,503

Previous 470,691 1.1%

Holding current value

$69.4 Million

Previous $84.6 Million 1.16%

% of portfolio

0.18%

Previous 0.19%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$170.78 - $208.42 $886,006 - $1.08 Million	-5,188 Reduced 1.1%	465,503 $85.6 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $12.1 Million - $19.6 Million	105,662 Added 28.95%	470,691 $84.6 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $1.89 Million - $2.41 Million	13,634 Added 3.88%	365,029 $58 Million
Q2 2023 Aug 11, 2023	SELL	$138.42 - $180.31 $1.29 Million - $1.67 Million	-9,285 Reduced 2.57%	351,395 $49.7 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $482,679 - $619,854	3,129 Added 0.88%	360,680 $60.7 Million

Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $574,641 - $780,341	-3,538 Reduced 0.98%	357,551 $60.5 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.75 Million - $2.79 Million	10,879 Added 3.11%	361,089 $67.6 Million
Q2 2022 Aug 08, 2022	BUY	$140.68 - $188.02 $829,871 - $1.11 Million	5,899 Added 1.71%	350,210 $56.9 Million
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $2.08 Million - $3.33 Million	12,910 Added 3.9%	344,311 $64.8 Million
Q4 2021 Feb 09, 2022	SELL	$247.59 - $304.47 $4.04 Million - $4.97 Million	-16,321 Reduced 4.69%	331,401 $87.8 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $12.7 Million - $21.2 Million	-65,305 Reduced 15.81%	347,722 $100 Million
Q2 2021 Aug 11, 2021	BUY	$165.87 - $220.95 $15.1 Million - $20.1 Million	91,164 Added 28.32%	413,027 $82.4 Million
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $2.76 Million - $3.46 Million	-15,288 Reduced 4.53%	321,863 $62.6 Million
Q4 2020 Feb 11, 2021	SELL	$148.08 - $206.57 $562,259 - $784,346	-3,797 Reduced 1.11%	337,151 $64.6 Million
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $1.62 Million - $2.1 Million	-13,255 Reduced 3.74%	340,948 $50.3 Million
Q2 2020 Oct 22, 2020	BUY	$94.33 - $140.48 $33.4 Million - $49.8 Million	354,203 New	354,203 $43.8 Million

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.27B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Repligen Corp Transaction History